Centerpoint Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-36
Closed -$2K 634
2022
Q4
$2K Hold
36
﹤0.01% 409
2022
Q3
$2K Hold
36
﹤0.01% 325
2022
Q2
$1K Hold
36
﹤0.01% 364
2022
Q1
$1K Hold
36
﹤0.01% 374
2021
Q4
$2K Buy
+36
New +$2K ﹤0.01% 342

Other funds holding PRTA

Centerpoint Advisors's PRTA Position: Q1 2023 in Review

Centerpoint Advisors sold out of Prothena Corp (PRTA) in Q1 2023, closing a stake of 36 shares — an estimated $2K sold.

Centerpoint Advisors first reported a position in PRTA in Q4 2021 and held it in 5 quarters. The position peaked at $2K in Q4 2022. 191 funds tracked by Wall St. Rank hold PRTA as of Q1 2023.

  • Centerpoint Advisors reported no remaining Prothena Corp position as of Q1 2023 after selling out during the quarter.
  • Centerpoint Advisors sold 36 Prothena Corp shares in Q1 2023, an estimated $2K.
  • Centerpoint Advisors first reported a position in Prothena Corp in Q4 2021 and held it in 5 quarters.
  • Centerpoint Advisors's Prothena Corp position peaked at $2K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2023.

Based on Centerpoint Advisors's 13F filing for Q1 2023, filed 3 May 2023.